(VIANEWS) – AbbVie (ABBV), Nuveen California AMT (NKX), Camden National Corporation (CAC) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. AbbVie (ABBV)
202.68% Payout Ratio
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Earnings Per Share
As for profitability, AbbVie has a trailing twelve months EPS of $2.71.
PE Ratio
AbbVie has a trailing twelve months price to earnings ratio of 59.88. Meaning, the purchaser of the share is investing $59.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 54.26%.
Previous days news about AbbVie (ABBV)
- Why AbbVie (abbv) outpaced the stock market today. According to Zacks on Monday, 9 September, "Analysts and investors alike will be keeping a close eye on the performance of AbbVie in its upcoming earnings disclosure. ", "Any recent changes to analyst estimates for AbbVie should also be noted by investors. "
2. Nuveen California AMT (NKX)
61.59% Payout Ratio
Nuveen California AMT-Free Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Asset Management, LLC and Nuveen Fund Advisors LLC. It invests in the fixed income markets of California, United States. The fund primarily invests in undervalued municipal securities and other related investments the income which are exempt from regular federal and California income taxes and are rated Baa, BBB or higher with an average maturity of 20.17 years. It employs fundamental analysis with a bottom-up approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's (S&P) California Municipal Bond Index and the S&P National Municipal Bond Index. It was formerly known as Nuveen California AMT-Free Municipal Income Fund. Nuveen California AMT-Free Quality Municipal Income Fund was formed on November 21, 2002 and is domiciled in the United States.
Earnings Per Share
As for profitability, Nuveen California AMT has a trailing twelve months EPS of $0.85.
PE Ratio
Nuveen California AMT has a trailing twelve months price to earnings ratio of 15.69. Meaning, the purchaser of the share is investing $15.69 for every dollar of annual earnings.
3. Camden National Corporation (CAC)
56.57% Payout Ratio
Camden National Corporation operates as the bank holding company for Camden National Bank that provides various commercial and consumer banking products and services for consumer, institutional, municipal, non-profit, and commercial customers. The company accepts checking, savings, time, and brokered deposits, as well as deposits with the certificate of deposit account registry system. It also offers non-owner-occupied commercial estate loans, owner-occupied commercial real estate loans, unsecured fully-guaranteed commercial loans backed by the U.S. small business administration, loans secured by one-to four-family properties, and consumer and home equity loans. In addition, the company provides brokerage and insurance services through its financial offerings consisting of college, retirement, estate planning, mutual funds, strategic asset management accounts, and variable and fixed annuities. Further, it offers a range of fiduciary and asset management, wealth management, investment management, financial planning, and trustee services. As of December 31, 2021, the company had 57 branches within Maine; one residential mortgage lending office in Braintree, Massachusetts; two locations in New Hampshire, including a branch in Portsmouth and a commercial loan production office in Manchester; and an online residential mortgage and small commercial digital loan platform, as well as 66 ATMs. Camden National Corporation was founded in 1875 and is headquartered in Camden, Maine.
Earnings Per Share
As for profitability, Camden National Corporation has a trailing twelve months EPS of $2.97.
PE Ratio
Camden National Corporation has a trailing twelve months price to earnings ratio of 13.49. Meaning, the purchaser of the share is investing $13.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.92%.
4. United Bankshares (UBSI)
55.47% Payout Ratio
United Bankshares, Inc., a financial holding company, primarily provides commercial and retail banking products and services in the United States. It operates through two segments, Community Banking and Mortgage Banking. The company accepts checking, savings, and time and money market accounts; individual retirement accounts; and demand deposits, statement and special savings, and interest-bearing checking accounts. Its loan products include commercial loans and leases; construction and real estate loans; personal, credit card, commercial, and floor plan loans; and credit card and home equity loans. In addition, the company provides credit cards; safe deposit boxes, wire transfers, and other banking products and services; investment and security services; services to correspondent banks, including buying and selling federal funds; automated teller machine services; and internet and telephone banking services. Further, it offers community banking services, such as asset management, real property title insurance, financial planning, mortgage banking, and brokerage services. As of January 28, 2021, the company operated 230 offices in West Virginia, Virginia, Ohio, Pennsylvania, Maryland, North Carolina, South Carolina, Georgia, and Washington, D.C. United Bankshares, Inc. was incorporated in 1982 and is headquartered in Charleston, West Virginia.
Earnings Per Share
As for profitability, United Bankshares has a trailing twelve months EPS of $2.65.
PE Ratio
United Bankshares has a trailing twelve months price to earnings ratio of 14.44. Meaning, the purchaser of the share is investing $14.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.56%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.4%, now sitting on 1.01B for the twelve trailing months.
Yearly Top and Bottom Value
United Bankshares’s stock is valued at $38.27 at 02:23 EST, under its 52-week high of $39.93 and way above its 52-week low of $25.35.
Volume
Today’s last reported volume for United Bankshares is 589975 which is 5.87% above its average volume of 557240.
Moving Average
United Bankshares’s worth is higher than its 50-day moving average of $35.78 and above its 200-day moving average of $34.84.
5. Middlefield Banc Corp. (MBCN)
41.24% Payout Ratio
Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the bank holding company of The Middlefield Banking Company with total assets of $1.39 billion at March 31, 2021. The bank operates 16 full-service banking centers and an LPL Financial® brokerage office serving Beachwood, Chardon, Cortland, Dublin, Garrettsville, Mantua, Middlefield, Newbury, Orwell, Plain City, Powell, Solon, Sunbury, Twinsburg, and Westerville. The Bank also operates a Loan Production Office in Mentor, Ohio. Additional information is available at www.middlefieldbank.bank.
Earnings Per Share
As for profitability, Middlefield Banc Corp. has a trailing twelve months EPS of $1.94.
PE Ratio
Middlefield Banc Corp. has a trailing twelve months price to earnings ratio of 14.42. Meaning, the purchaser of the share is investing $14.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.78%.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
